Table 2.
Primary and Secondary Outcomes – All Patients
All (n=1039) | PIV (n = 832) | IO (n = 207) | OR (95% CI) | p-Value | |
---|---|---|---|---|---|
| |||||
Primary Outcome | |||||
Survival to hospital discharge, n (%) | 279 (26.9) | 236 (28.4) | 43 (20.8) | 0.71 (0.47 – 1.06) | 0.09 |
Secondary Outcomes | |||||
Survival with favourable neurologic status, n (%) | 248 (23.9) | 210 (25.2) | 38 (18.4) | 0.74 (0.49 – 1.13) | 0.16 |
ROR, n (%) | 821 (79.0) | 671 (80.7) | 150 (72.2) | 0.68 (0.47 – 0.98) | 0.04 |
TTR, min ± SD | 9:40 ± 8:56 | 9:01 ± 8:40 | 12:38 ± 10:10 | -- | <0.001 |
Primary and secondary outcomes for All Patients. Odds ratios and p-values are adjusted for age, gender, initial rhythm, witnessed status and time-to-epinephrine.
IO = intraosseous; PIV = peripheral Intravenous; ROR = Rate-of-ROSC; TTR = Time-to-ROSC.